Summary
Using commercially available antigens, enzyme-linked immunosorbent assays (ELISAs) were set up to demonstrate antibodies of IgG class against Sm and SS-A. Anti-Sm antibodies were demonstrated in 40% of patients with systemic lupus erythematosus (SLE), in 12% of patients with Sjögren's syndrome, in 6% of patients with rheumatoid arthritis (RA) and in 12% of patients with miscellaneous rheumatic disorders. Anti-SS-A antibodies were seen in 63% of the SLE patients, in 37% of the patients with Sjögren's syndrome and in 23% of the patients with RA. In the patients with SLE, high levels of anti-Sm antibodies were related to the presence of Raynaud's phenomenon, whereas patients with a malar rash tended to have high levels of anti-SS-A antibodies. In 17 SLE patients followed over a period of time a correlation was seen between the levels of the anti-Sm antibodies and the disease activity. We concluded that it is useful to include ELISAs for the demonstration of anti-Sm and anti-SS-A antibodies in determining the serological profile and in the follow-up of patients with SLE.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Tan EM (1982) Autoantibodies to nuclear antigens (ANA): their immunology and medicine. Adv Immunol 33: 167–240
Notman DD, Kurata N, Tan EM (1975) Profiles of antinuclear antibodies in systemic rheumatic diseases. Ann Intern Med 83: 464–469
Hamburger M, Hodes S, Barland P (1977) The incidence and clinical significance of antibodies to extractable nuclear antigens. Am J Med Sci 273: 21–28
Winfield JB, Brunner CM, Koffler D (1978) Serologic studies in patients with systemic lupus erythematosus and central nervous system dysfunction. Arthritis Rheum 21: 289–294
Winn DM, Wolfe JF, Lindberg DA, Fristoe FH, Kingsland L, Sharp GC (1979) Identification of a clinical subset of systemic lupus erythematosus by antibodies to the Sm antigen. Arthritis Rheum 22: 1334–1337
Beaufils M, Kouki F, Mignon F, Camus J-P, Morel-Maroger L, Richet G (1983) Clinical significance of anti-Sm antibodies in systemic lupus erythematosus. Am J Med 74: 201–205
Barada FA, Andrews BS, Davis JS, Taylor RP (1981) Antibodies to Sm in patients with systemic lupus erythematosus. Arthritis Rheum 24: 1236–1244
Homma M, Mimori T, Takeda Y, Akama H, Yoshida T, Ogasawara T, Akizuki M (1987) Autoantibodies to the Sm antigen: immunological approach to clinical aspects of systemic lupus erythematosus. J Rheumatol 14: 188–193
Bell DA, Maddison PJ (1980) Serologic subsets in systemic lupus erythematosus. An examination of autoantibodies in relationship to clinical features of disease and HLA antigens. Arthritis Rheum 23: 1268–1273
Sontheimer RD, Maddison PJ, Reichlin M, Jordon RE, Stastny P, Gilliam JN (1982) Serologic and HLA associations in subacute cutaneous lupus erythematosus, a clinical subset of lupus erythematosus. Ann Intern Med 97: 664–671
Mond CB, Peterson MGE, Rothfield NF (1989) Correlation of anti-Ro antibody with photosensitivity rash in systemic lupus erythematosus patients. Arthritis Rheum 32: 202–204
Boulware DW, Hedgpeth MT (1989) Lupus pneumonitis and anti-SSA (Ro) antibodies. J Rheumatol 16: 479–481
van Venrooij WJ (1987) Autoantibodies against small nuclear ribonucleoprotein components. J Rheumatol 14: 78–82
Gripenberg M, Kurki P (1986) Demonstration of human autoantibodies by quantitative enzyme immunoassays. J Immunol Methods 92: 145–159
Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus Arthritis Rheum 25: 1271–1277
Maddison PJ, Skinner RP, Vlachoyiannopoulos P, Brennand DM, Hough D (1985) Antibodies to nRNP, SM, Ro(SSA) and La(SSB) detected by ELISA: their specificity and inter-relations in connective tissue disease sera. Clin Exp Immunol 62: 337–345
Gripenberg M, Piirainen H, Linder E (1981) Antibodies against polyriboadenylic acid in systemic lupus erythematosus and rheumatoid arthritis demonstrated by ELISA. Scand J Rheumatol 10: 33–37
Field M, Williams DG, Charles P, Maini RN (1988) Specificity of anti-Sm antibodies by ELISA for systemic lupus erythematosus: increased sensitivity of detection using purified peptide antigens. Ann Rheum Dis 47: 820–825
Combe B, Rucheton M, Graafland H, Lussiez V, Brunel C, Sany J (1989) Clinical significance of anti-RNP and anti-Sm autoantibodies as determined by immunoblotting and immunoprecipitation in sera from patients with connective tissue diseases. Clin Exp Immunol 75: 18–24
Scopelitis E, Biundo JJ Jr, Alspaugh MA (1980) Anti-SS-A antibody and other antinuclear antibodies in systemic lupus erythematosus. Arthritis Rheum 23: 287–293
Provost TT, Levin LS, Watson RM, Mayo M, Ratrie H III (1991) Detection of anti-Ro (SSA) antibodies by gel double diffusion and a “sandwich” ELISA in systemic and subacute cutaneous lupus erythematosus and Sjögren's syndrome. J Autoimmun 4: 87–96
yasuma M, Takasaki Y, Matsumoto K, Kodama A, Hashimoto H, Hirose S-I (1990) Clinical significance of IgG anti-Sm antibodies in patients with systemic lupus erythematosus. J Rheumatol 17: 469–475
Dillon CF, Verrier Jones J, Reichlin M (1983) Antibody to Ro in a population of patients with systemic lupus erythematosus: distribution, clinical and serological associations. J Rheumatol 10: 380–386
Scott JS, Maddison PJ, Taylor PV, Esscher E, Scott O, Skinner RP (1983) Connective-tissue disease, antibodies to ribonucleoprotein, and congenital heart block. N Engl J Med 309: 209–212
Habets WJ, de Rooij DJ, Hoet MH, van de Putte LB, van Venrooij WJ (1985) Quantitation of anti-RNP and anti-Sm antibodies in MCTD and SLE patients by immunoblotting. Clin Exp Immunol 59: 457–466
Whittingham S, Naselli G, McNeilage LJ, Coppel RL, Sturgess AD (1987) Serological diagnosis of primary Sjögren's syndrome by means of human recombinant La (SS-B) as nuclear antigen. Lancet II: 1–3
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gripenberg, M., Teppo, A.M. & Friman, C. Antibodies to Sm and SS-A demonstrated by enzyme immunoassay. Rheumatol Int 11, 209–213 (1991). https://doi.org/10.1007/BF00332564
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00332564